2026. Lymphocyte subset distribution can predict the efficacy of first-line treatment in patients with non-Hodgkin lymphoma. Clinical Medicine and Pharmacology. 3, 1 (Jan. 2026). DOI:https://doi.org/10.70731/1m330584.